IGHE and asthma: IgE-targeted therapy becomes a key driver in the treatment of asthma, attempting to lower the level of free IgE in blood and prevent degranulation of granulocytes (mast cells, basophils), following the binding of IgE to high-affinity IgE receptors on mast cells and basophils.